| 000 | 01369 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516142921.0 | ||
| 264 | 0 | _c20140124 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1875-5704 | ||
| 024 | 7 |
_a10.2174/1567201811310030012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBuys, Gerhard M | |
| 245 | 0 | 0 |
_aDirect compression of chitosan: process and formulation factors to improve powder flow and tablet performance. _h[electronic resource] |
| 260 |
_bCurrent drug delivery _cJun 2013 |
||
| 300 |
_a348-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xchemistry |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aCitric Acid _xchemistry |
| 650 | 0 | 4 | _aCompressive Strength |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 |
_aExcipients _xchemistry |
| 650 | 0 | 4 |
_aIsoniazid _xchemistry |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPectins _xchemistry |
| 650 | 0 | 4 | _aPowders |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTensile Strength |
| 700 | 1 | _adu Plessis, Lissinda H | |
| 700 | 1 | _aMarais, Andries F | |
| 700 | 1 | _aKotze, Awie F | |
| 700 | 1 | _aHamman, Josias H | |
| 773 | 0 |
_tCurrent drug delivery _gvol. 10 _gno. 3 _gp. 348-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1567201811310030012 _zAvailable from publisher's website |
| 999 |
_c22630247 _d22630247 |
||